Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.01 trillion as of February 4, 2025. Its market cap has decreased by -1.33% in one year.

Market Cap

2.01T

Enterprise Value

1.99T

Revenue

134.24B

Ranking

n/a

PE Ratio

n/a

Stock Price

39,950.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.01T, an increase of 7,554.95%. That is a compound annual growth rate of 15.87%.

Market Cap History

Date	Market Cap	% Change
Feb 4, 2025	2,013.20B	2.72%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	1,919.22B	3.31%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	77.94T
Celltrion	37.33T
Yuhan	9,232.03B
SK Biopharmaceuticals	8,081.93B
SK bioscience	3,705.83B
Hanmi Pharm.	2,967.17B
Hanmi Science	1,811.34B
Daewoong Pharmaceutical	1,516.53B

Market Cap Rankings